BioAnalysis, LLC
Michael DeLion has a strong background in analytics and research, with significant experience in the pharmaceutical and scientific industries. Michael most recently served as the Senior Director of Analytics and Research at BioAnalysis, LLC, a role they have held since January 2022. Prior to this, they worked as the Director of Analytics & Research at the same company from June 2021 to December 2023.
Before joining BioAnalysis, LLC, Michael held the position of Scientific Director at Triclinic Labs, Inc. from January 2010 to April 2021. Michael also worked as a Scientist at SSCI (Aptuit) from December 2004 to January 2010, and as an Analytical Chemist at Battelle from October 2001 to December 2004.
Michael DeLion earned their Bachelor of Science (BS) degree in Chemistry from Purdue University in the years 1995 to 1999.
This person is not in any teams
BioAnalysis, LLC
1 followers
A small, agile CRO. The primary function of the scientists at BioAnalysis, LLC is to provide a collaborative workspace that enables productive and effective solutions to the client’s problems. The traditional CRO model works well, however, at BioAnalysis, LLC we believe that collaborative interactions, communication and robust experimental design along with gold-standard quality results are the true value-added. The scientists of BioAnalysis, LLC possess a wealth of experience in characterization of therapeutic proteins, mAbs, and ADC (DARs), non-biologics (Polymers, PEO/PLA, nanoparticles), ICH/FDA regulatory applications, process development, and assessment of final biologic product formulations. Our subject matter expertise in the areas of Biophysics and Proteomics is showcased in over 70 peer reviewed publications.